# OnCo record momentum (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/momentum/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "momentum", "NCT04173494" ;
  schema:name "MOMENTUM"@en ;
  schema:description "MOMENTUM showed that momelotinib, a JAK inhibitor that also eases anaemia, relieved symptoms and shrank spleens better than danazol in people with myelofibrosis who were anaemic after earlier JAK inhibitor treatment."@en ;
  schema:url <https://onco.cc/trials/momentum/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04173494> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/primary-myelofibrosis/>, <https://onco.cc/cancers/myeloproliferative-neoplasms/> ;
  onco:drugs <https://onco.cc/drugs/momelotinib/>, <https://onco.cc/drugs/danazol/> ;
  onco:companies <https://onco.cc/companies/gsk/> ;
  onco:people <https://onco.cc/people/srdan-verstovsek/> .